Given the widespread involvement of MAP kinase pathways in cancer, the more concentrated involvement of HH/GLI in many tumor types, and the substantial evidence of crosstalk between these pathways, it is important to understand the molecular mechanisms of this crosstalk. The gene discussed is GLI1; the disease is neoplasm.